Safety and efficacy of high-dose infusions of a preformed amphotericin B fat emulsion for treatment of Indian visceral leishmaniasis

Sundar, S. ; Singh, A. ; Agarwal, D. ; Rai, M. ; Agrawal, N. ; Chakravarty, J. (2009) Safety and efficacy of high-dose infusions of a preformed amphotericin B fat emulsion for treatment of Indian visceral leishmaniasis The American Journal of Tropical Medicine and Hygiene, 80 (5). pp. 700-703. ISSN 0002-9637

Full text not available from this repository.

Official URL: http://www.ajtmh.org/content/80/5/700.abstract?sid...

Abstract

Amphotericin B deoxycholate is used as a first-line drug for visceral leishmaniasis (VL) in India. Its major drawbacks are prolonged hospitalization of treated patients and toxicity. An open label phase II study with pre-formed amphotericin B lipid emulsion (ABLE) was conducted to evaluate safety and efficacy of four regimens of 15 mg/kg each administered in 1-2 doses. Regimen 1 was 7.5 mg/kg/day on day 1 and day 3, and regimen 4 was a single bolus infusion of 15 mg/kg. The safety profile was excellent with mild infusion reactions seen in 38% of the patients. Definitive cure was achieved in 100% of the patients treated with regimen 4. The overall cure rate was 87% (95% confidence interval = 75-94%). In this study, ABLE was safe and had excellent efficacy when given as a bolus of 15 mg/kg. More studies with larger number of patients and higher doses are needed to establish acceptable, safe and efficacious regimen.

Item Type:Article
Source:Copyright of this article belongs to American Society of Tropical Medicine and Hygiene.
ID Code:71322
Deposited On:25 Nov 2011 07:29
Last Modified:25 Nov 2011 07:29

Repository Staff Only: item control page